121nexus: Cloud-based track & trace solutions for biomedical manufacturers!!


121nexus deploys cloud-based track and trace solutions for biomedical manufacturers. A recent report prepared by McKinsey and Co estimates that the cost of medical errors introduced by inadequate track and trace on medical devices is estimated to be between $18 and $115 billion annually. In response to the need in the industry for such a track and trace solution, 121nexus developed MDDTrack™, which is a cloud-based software solution for manufacturers to enhance recall management and post-market surveillance in the medical devices and diagnostics industry.


121nexus' technology solves a problem so critical to public health that it was awarded a National Science Foundation grant to accelerate commercialization of this unique approach to biomedical track and trace. 

Comments

Popular Posts